The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 trial of bevacizumab plus TPI 287, a brain penetrable anti-microtubule agent, in patients with recurrent glioblastoma.
 
Samuel Aaron Goldlust
Honoraria - Novocure
Consulting or Advisory Role - Novocure
Speakers' Bureau - Novocure
Research Funding - Acerta Pharma (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); ImmunoCellular Therapeutics (Inst); Northwest Biotherapeutics (Inst); Novocure (Inst); Tocagen (Inst); Wex Pharmaceuticals (Inst)
 
Louis B. Nabors
Consulting or Advisory Role - Cavion; Cortice Biosciences
 
Nimish Mohile
Consulting or Advisory Role - Novocure
 
Tara L. Benkers
Consulting or Advisory Role - Novocure
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; ImmunoCellular Therapeutics; Vascular Biogenics
 
Sigmund H. Hsu
Consulting or Advisory Role - Foundation Medicine
Research Funding - Cortice Biosciences (Inst); Foundation Medicine (Inst)
 
Sandra Silberman
No Relationships to Disclose
 
Samuel Singer
Consulting or Advisory Role - Novocure
 
George Farmer
Employment - Cortice Biosciences
Leadership - Cortice Biosciences (I)
Stock and Other Ownership Interests - Celgene; Cortice Biosciences; Synta
Speakers' Bureau - Cortice Biosciences